Stem cells could drive hepatitis research forward. Research out of the lab (see Schwartz et al, PNAS 2012) has established heptatitis C virus infection in liver-like cells derived from induced pluripotent stem cells (iPSCs), work that has been covered widely in the press, including MIT News.

Other coverage includes:

• Nature Methods
• "Editor's Choice" in Medical News Today
• News Medical
• DoctorsLounge